(11bR)-N-(2,6-Di(naphthalen-1-yl)-4-oxido-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

97%

Reagent Code: #231150
fingerprint
CAS Number 1227374-66-4

science Other reagents with same CAS 1227374-66-4

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 739.73 g/mol
Formula C₄₁H₃₃F₃NO₅PS
inventory_2 Storage & Handling
Storage Room temperature, light-proof, inert gas

description Product Description

Used as a chiral catalyst ligand in asymmetric synthesis, particularly in enantioselective transformations such as hydrogenation and cross-coupling reactions. Its rigid, sterically hindered structure enables high enantioselectivity and catalytic efficiency in the production of optically active pharmaceuticals and fine chemicals. Commonly employed with transition metals like palladium, rhodium, or iridium to form active catalytic complexes. Valued in medicinal chemistry for enabling the synthesis of single-enantiomer compounds with improved biological activity and reduced side effects.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance Solid
Purity (%) 96.5-100%
Infrared Spectrum Conforms to Structure
NMR Conforms to Structure

Available Sizes & Pricing

Size Availability Unit Price Quantity
50mg
10-20 days ฿2,880.00
100mg
10-20 days ฿4,270.00
250mg
10-20 days ฿10,660.00
1g
10-20 days ฿39,920.00
(11bR)-N-(2,6-Di(naphthalen-1-yl)-4-oxido-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide
No image available

Used as a chiral catalyst ligand in asymmetric synthesis, particularly in enantioselective transformations such as hydrogenation and cross-coupling reactions. Its rigid, sterically hindered structure enables high enantioselectivity and catalytic efficiency in the production of optically active pharmaceuticals and fine chemicals. Commonly employed with transition metals like palladium, rhodium, or iridium to form active catalytic complexes. Valued in medicinal chemistry for enabling the synthesis of singl

Used as a chiral catalyst ligand in asymmetric synthesis, particularly in enantioselective transformations such as hydrogenation and cross-coupling reactions. Its rigid, sterically hindered structure enables high enantioselectivity and catalytic efficiency in the production of optically active pharmaceuticals and fine chemicals. Commonly employed with transition metals like palladium, rhodium, or iridium to form active catalytic complexes. Valued in medicinal chemistry for enabling the synthesis of single-enantiomer compounds with improved biological activity and reduced side effects.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...